News Room

Hong Kong Science and Technology Parks Corporation (HKSTP) has launched the first cohort of its inaugural Smart Campus Challenge, “Robots Everywhere” Programme. The programme aims to recruit enterprises that are developing smart city and sustainable innovation technologies, providing them with adoption opportunities at Hong Kong Science Park to accelerate the implementation of innovation and technology in the market.

Hong Kong Science and Technology Parks Corporation (HKSTP) congratulates the record US$200 million joint venture between Prenetics and Professor Dennis Lo, hailing the launch of Insighta as a defining moment for Hong Kong as a fast-growing biomedical technology hub.

Immuno Cure BioTech (“Immuno Cure”) is pleased to announce today the initiation of a Phase IIa clinical trial of ICCOV, a COVID-19 DNA vaccine candidate. The clinical trial is initiated by Immuno Cure in collaboration with the University of Hong Kong (“HKU”) and will be conducted in Gleneagles Hospital Hong Kong (“Gleneagles”).

Hong Kong Science and Technology Parks Corporation (HKSTP) today announced the appointment of Ir Dr H.L. Yiu as Chief Corporate Development Officer, succeeding Mr Eugene Hsia at the end of his contract term.

Hong Kong Science and Technology Parks Corporation (HKSTP) and The Chinese University of Hong Kong (CUHK) today formally opened the Advanced Therapy Products (ATP) Good Manufacturing Practice (GMP) Centre located at the Hong Kong Institute of Biotechnology Limited (HKIB), adjoining the Science Park.

Hong Kong Science and Technology Parks Corporation (HKSTP) celebrated its Graduation Ceremony 2023 by announcing a total of 437* units from 21 economies from its Ideation, Incubation and Incu-bio Programmes.